NMDA Receptor Modulation for the Treatment of Bipolar I Disorder

Clinical trial NCT05977023 · RECRUITING

Trial details

NCT number: NCT05977023
Sponsor: China Medical University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2023-10-04
Primary completion: 2027-11-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.